Skip to content

Clinical trials

Expanded access Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Expanded access Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Available6
No longer available6
Approved for marketing3
Temporarily not available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Monopar Therapeutics2
Agenus Inc.1
AstraZeneca1
Bristol-Myers Squibb1
Christopher Dvorak1
Eli Lilly and Company1
Hope Biosciences LLC1
I-Mab Biopharma US Limited1
Jaime Leandro Foundation for Therapeutic Cancer Vaccines1
Kieuhoa Vo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms17
Recurrence3
Lymphoma2
Adenocarcinoma1
Adenoma, Islet Cell1
Bone Diseases1
Bone Diseases, Developmental1
Bone Marrow Diseases1
Bone Marrow Failure Disorders1
Carcinoma, Ovarian Epithelial1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.